Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 31, 2019Dermatologic Therapy

Nonmelanoma skin cancer associated with Hydroxyurea treatment: Overview of the literature and our own experience

View Full Paper
Ask AI
Bookmark
Share

Authors

CCCarmen CantisaniSapienza University of RomeNKNorbert KissSemmelweis UniversityANAhmad Faiq NaqeshbandiMichigan United

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cantisani et al. (2019) studied this question.

synapsesocial.com/papers/6a1ba65c90759efe6f0ca91bhttps://doi.org/10.1111/dth.13043
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Acitretin for chemoprevention of non‐melanoma skin cancers in renal transplant recipients2002 · 190 citations
  2. 2New Enlightenment of Skin Cancer Chemoprevention through Phytochemicals:In VitroandIn VivoStudies and the Underlying Mechanisms2014 · 66 citations
  3. 3Hydroxyurea‐related toxicity in 3,411 patients with Ph'‐negative MPN2012 · 135 citations
  4. 4The risks and benefits of long‐term use of hydroxyurea in sickle cell anemia: A 17.5 year follow‐up2010 · 484 citations
  5. 5Hydroxyurea for the Treatment of Psoriasis with an Emphasis on HIV-Infected Psoriasis Patients: A Review2011 · 14 citations